Weider tessa (4 resultados)

Autor: 
Refinar con la Búsqueda avanzada

Filtrar la búsqueda

  • Libros (4)

  • Nuevo (4)

a

Intervalo de precios personalizado (EUR)

a

  • Idioma: Inglés

    Editorial: GRIN Verlag, 2026

    3389179755 / 9783389179758

    • Tapa blanda

    Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 19,95

    Envío por EUR 35,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 1 disponible

    Taschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Seminar paper from the year 2025 in the subject Economics - Innovation economics, grade: 1,0, University of Hohenheim (Economics), course: Master Seminar in Innovation Economics, language: English, abstract: Red biotechnology, often described as medical biotechnology, represents one of the most transformative areas of modern science and healthcare. It encompasses the development of biopharmaceuticals, gene therapies, and personalized medicine strategies that are reshaping treatment approaches for numerous diseases. This seminar paper aims to examine the relationship of ethical public concerns and their influence on innovation in these fields The global biotechnology sector has experienced rapid growth, driven by advances in molecular biology, genetic engineering, and bioinformatics. Despite its enormous potential, red biotechnology also faces considerable challenges such as high research and development costs, ethical and regulatory complexity, and unequal access to advanced therapies.This paper also aims to examine whether there's a correlation between the ethical acceptance of human embryo genome editing, trust in regulatory institutions, and the benefit perception. This relationship is investigated among 109 medicine students at the University of Ulm through a quantitative survey. Core questions in the survey were whether they are willing to use techniques of gene editing and especially gene editing of embryos. This was tested under different risk factors. Finally, all participants were asked an open question about what they perceive as the biggest problem with human embryo gene editing.…

  • Idioma: Inglés

    Editorial: GRIN Verlag, GRIN Verlag Jan 2026, 2026

    3389179755 / 9783389179758

    • Tapa blanda
    • Impresión bajo demanda

    Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, AlemaniaBuchWeltWeit Ludwig Meier e.K.

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 19,95

    Envío por EUR 23,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 2 disponibles

    Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 36 pp. Englisch.

  • Idioma: Inglés

    Editorial: GRIN Verlag, GRIN Verlag Jan 2026, 2026

    3389179755 / 9783389179758

    • Tapa blanda
    • Impresión bajo demanda

    Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemaniabuchversandmimpf2000

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 19,95

    Envío por EUR 60,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 1 disponible

    Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Seminar paper from the year 2025 in the subject Economics - Innovation economics, grade: 1,0, University of Hohenheim (Economics), course: Master Seminar in Innovation Economics, language: English, abstract: Red biotechnology, often described as medical biotechnology, represents one of the most transformative areas of modern science and healthcare. It encompasses the development of biopharmaceuticals, gene therapies, and personalized medicine strategies that are reshaping treatment approaches for numerous diseases. This seminar paper aims to examine the relationship of ethical public concerns and their influence on innovation in these fields The global biotechnology sector has experienced rapid growth, driven by advances in molecular biology, genetic engineering, and bioinformatics. Despite its enormous potential, red biotechnology also faces considerable challenges such as high research and development costs, ethical and regulatory complexity, and unequal access to advanced therapies.This paper also aims to examine whether there's a correlation between the ethical acceptance of human embryo genome editing, trust in regulatory institutions, and the benefit perception. This relationship is investigated among 109 medicine students at the University of Ulm through a quantitative survey. Core questions in the survey were whether they are willing to use techniques of gene editing and especially gene editing of embryos. This was tested under different risk factors. Finally, all participants were asked an open question about what they perceive as the biggest problem with human embryo gene editing.Books on Demand GmbH, Überseering 33, 22297 Hamburg 36 pp. Englisch. …

  • Idioma: Inglés

    Editorial: GRIN Verlag, 2026

    3389179755 / 9783389179758

    • Tapa blanda
    • Impresión bajo demanda

    Librería: preigu, Osnabrück, Alemaniapreigu

    Vendedor de 5 estrellas
    Contactar con el vendedor

    Condición: Nuevo

    EUR 19,95

    Envío por EUR 70,00 
    Se envía de Alemania a Estados Unidos de America

    Cantidad disponible: 5 disponibles

    Taschenbuch. Condición: Neu. Red Biotechnology Between Innovation and Ethics. Human Embryo Editing | Tessa Weider | Taschenbuch | Englisch | 2026 | GRIN Verlag | EAN 9783389179758 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu Print on Demand. …